HeartGenetics, Genetics and Biotechnology SA is a Portuguese biotech and bioinformatics company developing new medical devices (genetic testing kits and AI software tools) that makes genetic testing simple, actionable and cost-effective and that can be used on cardiovascular diagnosis, pharmacogenetics and nutrigenetics.
The company will use the new financing to grow its products in genetic molecular diagnostics and expand to new international markets. With this investment, the company will continue to develop its core technology and the marketing of the products to help serving the customers better.
Beta Capital welcomes HearGenetics and its team!
Check HeartGenetics’ website here.